AveXis Releases New Data on Phase 1 Clinical Trial
AveXis has released new data from their current Phase 1 clinical trial testing AVXS-101, a systemic delivery of gene therapy for SMA. The data from this initial trial will inform future clinical studies of gene therapy approaches. “The past six months has been a period of significant progress for AveXis, as we completed a successful […]
AveXis Releases New Data on Phase 1 Clinical Trial Read More »